| Old Articles: <Older 3101-3110 Newer> |
 |
Pharmaceutical Executive September 1, 2006 Sarah Houlton |
Global Report: Break with Tradition Pharma's battle against animal-rights activists has been long-lasting and decidedly uphill. But now, with Prime Minister Tony Blair on its side, industry sees light at the end of the tunnel.  |
Pharmaceutical Executive September 1, 2006 |
Thoughtleader: Small Cost, Big Win CEO J.J. Finkelstein discusses why outsourcing suits RegeneRx, how he manages to stay in control of operations, and why he's still able to sleep at night.  |
Pharmaceutical Executive September 1, 2006 Reznick & Kobak |
Legal: Authorized Generics: Still Legal--and Holding Despite the rattle and hum, courts continue to support the practice of authorized generics. The response? Generic manufacturers are changing the way they argue these cases.  |
Pharmaceutical Executive September 1, 2006 Richard B. Vanderveer |
The Information Diet How, when, and why physicians consume information.  |
Pharmaceutical Executive September 1, 2006 Jeannette Park |
Directo to Consumer: No-Name Opportunity Marketers are using unbranded ads to get across the right messages.  |
Pharmaceutical Executive September 1, 2006 Eleanor O'Rangers |
Marketing to Professionals: Savvy Strategists Ahead-of-the-curve brand teams are bringing in medical experts with marketing knowledge.  |
Pharmaceutical Executive September 1, 2006 Scott Burkette |
Alternative Media: The Download on Podcasting Through podcasts, marketers create intimate and captivating experiences for audiences.  |
Pharmaceutical Executive September 1, 2006 |
Finance: Good Alternatives With more ways to raise cash, biotechs with hot products can extend their independence.  |
The Motley Fool September 7, 2006 Brian Lawler |
SkyePharma Makes a Deal The pharmaceutical sells European rights to a promising asthma drug. With approval not guaranteed, and a cutthroat market for asthma drugs, this deal looks pretty good for Skye overall.  |
HBS Working Knowledge September 6, 2006 Deborah Blagg |
Mixing Students and Scientists in the Classroom In his course on commercializing science and technology, Lee Fleming combines students from business, engineering, law, science, and medicine. The result: Ideas for products from scale-eating bacteria to quantum dot cancer treatments.  |
| <Older 3101-3110 Newer> Return to current articles. |